StockNews.com began coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Free Report) in a research note published on Tuesday morning. The firm issued a sell rating on the stock.
Ampio Pharmaceuticals Stock Performance
AMPE stock opened at $0.23 on Tuesday. Ampio Pharmaceuticals has a 1 year low of $0.14 and a 1 year high of $8.30. The stock has a market capitalization of $256,500.00, a price-to-earnings ratio of -0.02 and a beta of 2.14. The stock’s fifty day moving average is $0.98 and its two-hundred day moving average is $1.73.
Ampio Pharmaceuticals (NYSE:AMPE – Get Free Report) last issued its quarterly earnings data on Wednesday, March 27th. The company reported ($2.48) earnings per share for the quarter.
About Ampio Pharmaceuticals
Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.
Featured Articles
- Five stocks we like better than Ampio Pharmaceuticals
- Insider Buying Explained: What Investors Need to Know
- Garmin Navigates to New Highs Driven By Wearables Trend
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Pinterest Prospers From AI Boosting Shop-Ability and Relevance
- Investing In Preferred Stock vs. Common Stock
- AbbVie Tracking for New Highs in 2024
Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
